Results 31 to 40 of about 122,669 (246)

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Hepatology, 2019
Over the past 2 decades, nonalcoholic fatty liver disease (NAFLD) has grown from a relatively unknown disease to the most common cause of chronic liver disease in the world.
Z. Younossi, F. Tacke, M. Arrese, Barjesh Chander Sharma, I. Mostafa, E. Bugianesi, V. Wai‐Sun Wong, Y. Yılmaz, J. George, Jian-Gao Fan, M. Vos   +10 more
semanticscholar   +1 more source

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives

Metabolites, 2018
In recent years, metabolomics has attracted great scientific attention. The metabolomics methodology might permit a view into transitional phases between healthy liver and nonalcoholic steatohepatitis.
Stefano Gitto, Filippo Schepis, Pietro Andreone, Erica Villa   +3 more
doaj   +1 more source

In vivo diffuse reflectance spectroscopic analysis of fatty liver with inflammation in mice

Surgery Open Science, 2021
Background: Nonalcoholic steatohepatitis is a progressive liver disease that can lead to cirrhosis, hepatocellular carcinoma, and hepatic failure. Thus, the diagnosis of nonalcoholic steatohepatitis, especially discrimination from nonalcoholic fatty ...
Yasuhiro Takihata, MD, Satoko Kawauchi, PhD, Sho Ogata, MD, PhD, Izumi Nishidate, PhD, Shunichi Sato, PhD, Junji Yamamoto, MD, PhD, Yoji Kishi, MD, PhD   +6 more
doaj   +1 more source

Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis

Periodontology, 2021
Periodontal disease, a chronic inflammatory disease of the periodontal tissues, is not only a major cause of tooth loss, but it is also known to exacerbate/be associated with various metabolic disorders, such as obesity, diabetes, dyslipidemia, and ...
Ryutaro Kuraji, S. Sekino, Y. Kapila, Y. Numabe   +3 more
semanticscholar   +1 more source

Adipokines in a group of mexican patients with nonalcoholic steatohepatitis

Annals of Hepatology, 2009
Introduction: Leptin has been implicated in the pathogenesis of nonalcoholic steatohepatitis. It has also beensuggested that adiponectin plays an important role in the transition from fatty liver disease to nonalcoholic steatohepatitis.Objective: To ...
Linda E. Muñoz, Paula Cordero, Liliana Torres, Alma Y. Sauceda, Juan P. Flores, Jose J. Segura   +5 more
doaj   +1 more source

NASH and Systemic Complications: From Basic to Clinical Research

Biomedicines, 2021
Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH) [...]
Sabine Baumgartner, Ronit Shiri-Sverdlov
doaj   +1 more source

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments [PDF]

Clinical and Molecular Hepatology, 2023
Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis.
Sang Bong Ahn
doaj   +1 more source

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

BMC Gastroenterology, 2005
Background Oxidative stress, an increase in oxidants and/or a decrease in antioxidant capacity, is one of the potential biochemical mechanisms involved in the pathogenesis of nonalcoholic steatohepatitis.
Sarifakiogullari Serpil, Aslan Mehmet, Sabuncu Tevfik, Bolukbas Fusun F, Bolukbas Cengiz, Horoz Mehmet, Gunaydin Necla, Erel Ozcan   +7 more
doaj   +1 more source

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

Balkan Journal of Medical Genetics, 2023
This study aimed at exploring the mechanisms underlying nonalcoholic fatty liver disease (NAFLD) and developing new diagnostic biomarkers for nonalcoholic steatohepatitis (NASH).
Chen X., Zhang L., Wang Y., Li R., Yang M., Gao L.   +5 more
doaj   +1 more source

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension

Patologìâ, 2013
The article is devoted to the study of clinical and pathogenetic peculiarities of nonalcoholic steatohepatitis, a condition of components of connective tissue, metabolic intoxication, hemostasis and fi brinolysis by comorbidity with and without stage II
O.S. Khukhlina, O.E. Mandryk, A.A. Antoniv   +2 more
doaj   +1 more source